Skip to main content
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
About us
About us
Governance
IDDO Team
Our partners
Contact us
Jobs
Data
Explore data
Accessing data
Data Access Guidelines
Contributing data
Why share your data
Frequently Asked Questions
IDDO legal and regulatory documentation
Science
Science
WWARN malaria
COVID-19
Ebola
Visceral leishmaniasis
Medicine Quality
Antimicrobial Resistance
Schistosomiasis & STHs
Chagas Disease
Febrile illness
Scrub typhus
Trachoma
Other diseases
Equity
Our approach
IDDO Blogs
News
Publications
LOGIN
Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation
Resources for researchers
Downloadable resources for researchers
i
Photo: Arne Hoel, World Bank
Country Antimalarial Drug Policies
Document
Artemether-Lumefantrine Dose Impact Study Group Acknowledgements
Document
Artesunate-Amodiaquine Dose Impact Study Group Acknowledments
Document
Primaquine Literature Review Recurrence Scatter plots 1-4
Document
Primaquine Literature Review Key Components Studies
Document
Primaquine Literature Review Search Terms
Document
Introduction to Population PK
Document
Promoting the Quality of Medicines
Document
Dihydroartemisinin-Piperaquine Dose Impact Study Group Acknowledgements
Document
Primaquine Literature Review Profile
Document
Pagination
First page
« First
Previous page
‹‹
…
Page
3
Page
4
Page
5
Page
6
Current page
7
Page
8
Page
9
Page
10
Page
11
…
Next page
››
Last page
Last »
Research Agenda Development Process
View process
